TZUTC: -0500   
   MSGID: 1288.consprcy@1:2320/105 2ced17d1   
   PID: Synchronet 3.21a-Linux master/123f2d28a Jul 12 2025 GCC 12.2.0   
   TID: SBBSecho 3.28-Linux master/123f2d28a Jul 12 2025 GCC 12.2.0   
   BBSID: CAPCITY2   
   CHRS: ASCII 1   
   FORMAT: flowed   
   From TLDR 2025-07-28   
      
    ELON MUSK'S NEURALINK JOINS STUDY WORKING TOWARD A BIONIC EYE (1   
   MINUTE READ) [5]    
      
    Neuralink is collaborating with researchers in California and Spain   
   on a clinical trial to study visual prosthetics. The study, sponsored   
   by the University of California at Santa Barbara, aims to address the   
   fundamental questions that will allow the development of a Smart   
   Bionic Eye. Such a device would use AI to help blind people identify   
   faces, navigate the outdoors, and read, among other things. The   
   study's description says that researchers will use Neuralink patients   
   'once available'. Neuralink is developing a brainchip called   
   Blindsight that aims to restore vision to blind people and grant   
   superhuman vision.    
      
    CHINA'S UNITREE OFFERS A HUMANOID ROBOT FOR UNDER $6,000 (2 MINUTE READ) [7]   
      
    Unitree Robotics's R1 bot has a starting price of 39,900 yuan, or   
   around $5,900. Weighing just 25 kilograms, it has 26 joints and is   
   equipped with multimodal artificial intelligence, including voice in   
   image recognition. If it works as advertised, the new robot marks a   
   milestone for the robotics industry. Chinese companies are pushing   
   ahead with humanoids for factories, households, and even military use   
   - pricing is crucial to their proliferation.    
      
    THE FIRST 100% EFFECTIVE HIV PREVENTION DRUG IS APPROVED AND GOING   
   GLOBAL (4 MINUTE READ) [8]    
      
    The US Food and Drug Administration has approved lenacapavir, a drug   
   that offers 100% protection against HIV with twice-yearly injections.   
   Sold under the brand name Yeztugo, lenacapavir is a capsid inhibitor.   
   It stops the virus from entering cells and copying itself. Gilead has   
   made moves to ensure the drug is affordable - eligible uninsured   
   individuals will likely be able to access the drug free of cost   
   through its Advancing Access medication assistance program.    
      
   Links:   
   ------   
   [5] https://www.bloomberg.com/news/articles/2025-07-25/elon-musk-s-neuralink-jo   
   ins-study-working-toward-a-bionic-eye?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6I   
   kpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc1MzY1NDI2MCw   
   iZXhwIjoxNzU0MjU5MDYwLCJhcnRpY2xlSWQiOiJTWllWUzhHUEwzWE8wMCIsImJjb25uZWN0SWQiOi   
   JBOEExRDhFQTI5OTc0OTRGQTQ1QUE2REJBMjAwNTM3MSJ9.IlmD0ekOvE4Y1KTgHE1nXZh011fYOtUN   
   dPrGMDQi2Uw&utm_source=tldrnewsletter   
   [7] https://www.bloomberg.com/news/articles/2025-07-25/china-s-unitree-r1-is-a-   
   humanoid-robot-costing-less-than-6-000?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6   
   IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc1MzY1NDIzNi   
   wiZXhwIjoxNzU0MjU5MDM2LCJhcnRpY2xlSWQiOiJTWDRDOFpUMEFGQjQwMCIsImJjb25uZWN0SWQiO   
   iJBOEExRDhFQTI5OTc0OTRGQTQ1QUE2REJBMjAwNTM3MSJ9.W9zmqp8qC19Z67ye0NF10xzvxJEKag9   
   Z2t7jtCh6eiY&utm_source=tldrnewsletter   
   [8] https://newatlas.com/infectious-diseases/hiv-prevention-fda-lenacapavir/?ut   
   m_source=tldrnewsletter   
      
    -- https://tldr.tech/tech   
      
   $$   
   --- SBBSecho 3.28-Linux   
    * Origin: capitolcityonline.net * Telnet/SSH:2022/HTTP (1:2320/105)   
   SEEN-BY: 105/81 106/201 128/187 129/14 305 153/7715 154/110 218/700   
   SEEN-BY: 226/30 227/114 229/110 111 206 300 307 317 400 426 428 664   
   SEEN-BY: 229/700 705 266/512 291/111 320/219 322/757 342/200 396/45   
   SEEN-BY: 460/58 712/848 902/26 2320/0 105 304 3634/12 5075/35   
   PATH: 2320/105 229/426